Varex Imaging Corporation (VREX) carries a Roarable Rating of D+ (Sell) with 52/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Varex Imaging Corporation (VREX) slipped -0.05% to $18.44, trading at 98% of its 52-week range ($9.09 – $18.63). Stretched risk/reward at current multiples (-3% return on capital) under elevated 10-year interest-rate pressure.
Stockholders of Varex Imaging (NASDAQ:VREX) approved the company’s proposed merger with Teledyne Technologies Incorporated at a special meeting, clearing a key shareholder-vote requirement for the transaction. Under the
Independent Director and Seasoned Healthcare Executive Walt Rosebrough Elected Executive Chair; Search for CEO UnderwayProvides Update on Board Refreshment, Including Planned Addition of Medical Device and Vision Veteran
THOUSAND OAKS, Calif., October 21, 2026--Teledyne Technologies Incorporated (NYSE:TDY)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +4.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on VREX today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for VREX. Explore sector supply chains on /butterfly.
Across 714 tracked Technology securities in the Roarable RQD universe, Varex Imaging Corporation (VREX) ranks #377 by composite RQD confidence (52/100, grade D+) and #377 by equity capitalization ($776.3M). Within this direct 5-issuer industry benchmark cohort, ERII leads on earnings valuation at 15.8x trailing P/E, while CRCT leads on capital efficiency and profitability with 85.0% ROIC and 55.1% gross margin. CRCT currently holds the highest overall quantitative score in the immediate peer group at 80/100 (B+) compared with VREX at 52/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| VREX
ACTIVE
Varex Imaging Corporation | D+ | 52/100 | — | 34.4% | -3.0% | -0.05% | $776.3M | Benchmark Subject |
| NANO Forge Nano Holdings Inc. | D+ | 58/100 | — | — | — | -1.42% | $535.2M | /nano-vs-vrex → |
| CRCT Cricut Inc. (Class A) | B+ | 80/100 | 16.9x | 55.1% | 85.0% | +1.81% | $1.29B | /crct-vs-vrex → |
| ERII Energy Recovery Inc. | B | 72/100 | 15.8x | 65.1% | 11.9% | +2.45% | $363.4M | /erii-vs-vrex → |
| AZTA Azenta Inc. | D | 51/100 | — | 45.5% | -1.5% | +1.58% | $1.81B | /azta-vs-vrex → |
In its most recent audited fiscal period (FY2025, filed 2025-10-03), Varex Imaging Corporation (VREX) reported GAAP revenue of $844.6M (+4.1% vs. FY2024 revenue of $811.0M , and -5.5% cumulative change since FY2023) , GAAP net income of -$70.3M, operating cash flow of $41.7M, and free cash flow of $18.8M (-7.8% YoY). On the balance sheet, VREX closed FY2025 with $1.10B in total assets against $366.2M in total debt (Altman Z-Score: 1.96, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-10-03 | $844.6M | -$70.3M | $41.7M | $18.8M | $1.10B | $366.2M |
| FY2024 (FY) | 2024-09-27 | $811.0M | -$48.8M | $47.3M | $20.4M | $1.33B | $565.6M |
| FY2023 (FY) | 2023-09-29 | $893.4M | $47.4M | $108.4M | $108.4M | — | — |
As of 2026-11-01, Varex Imaging Corporation (NASDAQ: VREX) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 52/100 at a spot price of $18.44 (-0.05% 1D, market cap $776.3M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 8/20. Across 714 tracked Technology issuers, VREX ranks #377 in composite RQD confidence.
Within the Technology sector (Industrial Machinery/Components), VREX carries a Roarable D+ (52/100 RQD), trailing P/E of N/A, gross margin of 34.4%, and ROIC of -3.0%. By comparison, NANO (Forge Nano Holdings Inc.) holds a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $535.2M) and CRCT (Cricut Inc. (Class A)) posts a B+ grade (80/100 RQD, P/E 16.9x, ROIC 85.0%, cap $1.29B). Among the 5-stock peer group, ERII leads on earnings multiple (15.8x) while CRCT leads on capital efficiency (85.0% ROIC).
Per VREX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-10-03, CIK 0001681622), Varex Imaging Corporation generated $844.6M in revenue (+4.1% YoY), -$70.3M in net income, and $18.8M in free cash flow against $1.10B in total assets and $366.2M in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
VREX last traded at $18.44 (-0.05% on volume of 1,043,534 shares), positioning the stock -0.11% below its 50-day simple moving average ($18.46) and +35.59% above its 200-day simple moving average ($13.60). Across its 52-week range of $9.09 to $18.63, VREX sits at the 98.0% percentile with a 14-day RSI of 59.7 (BULLISH MOMENTUM) and an implied next-earnings move of ±1.8% ($18.11 to $18.77).
Why VREX Stock slipped -0.05% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-3% return on capital) under elevated 10-year interest-rate pressure.